The <a href="https://www.neptune-study.org/">Nephrotic Syndrome Study Network</a> (NEPTUNE) is a collaborative investigational infrastructure of 40 North American sites for conducting clinical and translational research in <a href="https://nephcure.org/livingwithkidneydisease/ns-and-other-glomerular-diseases/understanding-fsgs/">Focal Segmental Glomerulosclerosis</a> (FSGS), <a href="https://nephcure.org/livingwithkidneydisease/ns-and-other-glomerular-diseases/membranous-nephropathy-mn/">Membranous Nephropathy</a> (MN), and <a href="https://nephcure.org/livingwithkidneydisease/ns-and-other-glomerular-diseases/understanding-minimal-change-disease/">Minimal Change Disease</a> (MCD). NEPTUNE provides prospective, un-blinded, standardized evaluation of clinical and molecular outcomes in two cohorts: A) adults and children with incident or prevalent, biopsy-proven FSGS, MN, or MCD, recruited at the time of first biopsy, and B) children with incident Nephrotic Syndrome without a diagnostic kidney biopsy.

The Nephrotic Syndrome Study Network (NEPTUNE)

17 variables across Demographics, Disease Events, Race and Ethnicity

The Nephrotic Syndrome Study Network (NEPTUNE)

Demographics (3)

Disease Events (1)

Race and Ethnicity (1)

Other (12)